New vaccine combo aims to boost Body's fight against advanced skin cancer
Disease control
Ongoing
This study is testing whether adding one of two experimental cancer vaccines (SCIB1 or iSCIB1+) to standard immunotherapy drugs can help people with advanced, inoperable melanoma. The goal is to see if the vaccines make the standard treatments work better and longer for patients.…
Phase: PHASE2 • Sponsor: Scancell Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC